Inari Medical (Nasdaq:NARI) announced that it priced an underwritten public offering worth up to $186.3 million in proceeds. Irvine, California-based Inari Medical’s offering includes 2 million shares of its common stock at a public offering price of $81 per share before underwriting discounts and commissions. In addition, the company granted the underwriters a 30-day option […]
Inari Medical
Inari Medical to raise $156m in upsized IPO
Inari Medical (NSDQ:NARI) announced that it upsized its initial public offering of common stock shares for total gross proceeds of approximately $156 million. Earlier this week, the venous disease treatment developer announced that it launched the roadshow for its initial public offering (IPO) of shares of its common stock, planning to offer more than 7.3 million […]
Inari Medical plans to launch IPO to raise more than $110m
Inari Medical announced today that it launched the roadshow for its initial public offering (IPO) of shares of its common stock. The venous disease treatment developer is offering more than 7.3 million shares of common stock with an expected additional 30-day option for underwriters to purchase close to 1.1 million more shares. Irvine, Calif.-based Inari […]
Cutera snags Vyaire Medical’s Mowry for CEO | Personnel Moves, July 9, 2019
Cutera (NSDQ:CUTR) said today that it snagged Vyaire Medical CEO David Mowry to be its new CEO, effective immediately. The aesthetic device maker in January fired president & CEO James Reinstein after the company missed expectations for its 2018 top line, naming COO Jason Richey as interim chief executive. Mowry led Tornier to a $3.3 billion […]
Inari begins ClotTriever outcome study
Inari Medical said it has enrolled the first patient in the ClotTriever Outcomes Registry (“CLOUT”) using its ClotTriever thrombectomy system. The ClotTriever device is designed to remove blood clots from large vessels in the peripheral vasculature via access sites as small as 6 mm. CLOUT is a 500-patient prospective, multicenter, single-arm registry to evaluate real-world […]
Inari Medical wins FDA 510(k) for FlowTriever
Inari Medical said today it won FDA 510(k) clearance for its FlowTriever stent retriever designed to treat pulmonary embolisms. The clearance came based upon results from the company’s Flare clinical study of the device, which examined data from 106 patients with acute pulmonary embolisms treated with the FlowTriever at 18 US sites, the Irvine, Calif.-based company […]
Inari Medical touts FlowTriever pulmonary embolism study data
Inari Medical today presented results from a study of its FlowTriever retrieval and aspiration system designed to treat pulmonary embolism, touting the safety and efficacy of the system. Results were presented by Dr. Thomas Tu of Louisville, Ky.’s Baptist Health in San Diego at the Scientific Sessions of the Society for Cardiovascular Angiography and Interventions, […]
Inari Medical raises $27m
Inari Medical said today it closed a $27 million Series C round of financing, with funds slated to support commercialization of its FlowTriever and ClotTriever catheters designed for the treatment of venous thromboembolisms. Irvine, Calif.-based Inari’s ClotTriever device is designed to remove blood clots from large vessels in the peripheral vasculature, while it’s FlowTriever device is […]
Inari Medical wins FDA nod for ClotTriever peripheral thrombectomy device
Inari Medical said today that the FDA granted pre-market approval in February for its ClotTriever thrombectomy device Feb. 16 and already has the 1st commercial procedure under its belt. Irvine, Calif.-based Inari said the ClotTriever device is designed to remove blood clots from large vessels in the peripheral vasculature. The company also makes the FlowTriever device, which […]
FDA approves trial for Inari Medical’s clot-busting FlowTriever
Inari Medical said today that it won an investigational device exemption from the FDA for a clinical trial of its FlowTriever device, which is designed to retrieve pulmonary embolisms. Irvine, Calif.-based Inari said it expects to begin enrollment in the 150-patient Flare trial in the coming weeks. The primary safety endpoint is major adverse events within 48 hours, […]
Inari Medical raises $6m
Inari Medical today released information on a new $6.1 million equity funding round to support its business and thrombectomy system, according to an SEC filing. Inari produces the FlowTriever thrombectomy system, which is an FDA approved catheter-based thrombectomy device designed to remove clots in the peripheral vasculature, Inari Medical said. The device won FDA 510(k) […]
